The Single Best Pot Stock to Buy in October

If you can take the wait, this pot stock could be well worth it in the next decade or more, even with shares down 70% this year alone.

| More on:
A cannabis plant grows.

Source: Getty Images

October seems like a really good time to discuss the best pot stock, doesn’t it? After all, it wasn’t long ago that October saw pot stocks in general reach their peak. Back in 2018, on the event of legalization, it seemed like we couldn’t do wrong when it came to cannabis stocks.

But by the next day, it turns out we certainly could. Pot stocks fell significantly, leading to a drop that continues to this day. And in this current economic environment, it certainly doesn’t look like it’ll be improving anytime soon.

However, if you were a smart investor, you would have bought up a pot stock as a long-term hold. With that in mind, right now stinks, sure. But over time the right pot stock will still lead you to significant gains.

How can you say that?

It’s true, looking back over the last few years, most any pot stock you came across has likely performed poorly. But let’s be real here. Cannabis use isn’t going anywhere. Governments around the world are moving towards legal use, or at least decriminalization. This has already occurred in Canada, but what everyone is really waiting on is the United States.

I’m pretty sure if President Joe Biden could, he’d legalize pot tomorrow. Not because I think he’s a stoner, but because it’s a cash cow waiting to be milked! State after state continues to legalize marijuana, and they’re seeing an influx of cash relative to that of alcohol production.

It’s this that makes the future bright for a select few companies. But that means it’s all about choosing the right pot stock. And today, I continue to believe that stock should be Canopy Growth (TSX:WEED)(NASDAQ:CGC).

A pot stock focused on U.S. growth

Canopy Growth stock has been focused on growth in the United States since the beginning. It’s this focus that led to a superb rise, and major partnerships with companies like Constellation Brands. Further, it’s also led to several acquisitions over the past years that should come to fruition under federal legalization in the country.

But this is a long waiting game that has yet to pay dividends. In fact, the company has had to make cost cuts and layoffs, and focus on non-cannabis initiatives to bring in revenue such as its BioSteel brand. So what started as a pure focus, has shifted to a focus on profit.

That’s good for today’s investor who has yet to purchase Canopy Growth stock. The pot stock is now incredibly cheap at just $3.40 per share. That’s a massive decrease from its all-time highs around $70. In 2022, shares are down 70% year to date. Even so, it’s a responsible company if you look at the numbers. It would take just 94.7% of its equity to cover all its debts. That makes it a good buy even at these low levels.

The future is waiting

Federal legalization will happen eventually, if only because of the cash and potential tax revenue that will be generated throughout the country. When that happens, Canopy Growth stock will end its waiting period in the wings and become potentially the world’s largest pot stock in the country with the world’s largest consumption of cannabis. So if you can wait, it could be well worth it, but perhaps only by buying the shares at these insanely low prices.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »